These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 15283822

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Buprenorphine substitution ameliorates spontaneous withdrawal in fentanyl-dependent rat pups.
    Lohmann AB, Smith FL.
    Pediatr Res; 2001 Jan; 49(1):50-5. PubMed ID: 11134491
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Changes in urination/defecation, auditory startle response, and startle-induced ultrasonic vocalizations in rats undergoing morphine withdrawal: similarities and differences between acute and chronic dependence.
    Kalinichev M, Holtzman SG.
    J Pharmacol Exp Ther; 2003 Feb; 304(2):603-9. PubMed ID: 12538812
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Interaction of combined administration of intrathecal morphine with subcutaneous morphine or buprenorphine.
    Chen LH, Nemirovsky A, Gong QY.
    Acta Pharmacol Sin; 2000 Aug; 21(8):685-9. PubMed ID: 11501175
    [Abstract] [Full Text] [Related]

  • 10. Mirtazapine, a noradrenergic and specific serotonergic antidepressant, attenuates morphine dependence and withdrawal in Sprague-Dawley rats.
    Kang L, Wang D, Li B, Hu M, Zhang P, Li J.
    Am J Drug Alcohol Abuse; 2008 Aug; 34(5):541-52. PubMed ID: 18618337
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK, Bhateja P, Singh TG, Singh N.
    Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Characterization of neonatal rat fentanyl tolerance and dependence.
    Thornton SR, Smith FL.
    J Pharmacol Exp Ther; 1997 Apr; 281(1):514-21. PubMed ID: 9103539
    [Abstract] [Full Text] [Related]

  • 17. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
    Cavun S, Göktalay G, Millington WR.
    J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Buprenorphine, morphine and naloxone effects during ascending morphine maintenance in humans.
    Schuh KJ, Walsh SL, Bigelow GE, Preston KL, Stitzer ML.
    J Pharmacol Exp Ther; 1996 Aug; 278(2):836-46. PubMed ID: 8768738
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.